Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2009-08-17 13:43:33

Language is a central element of social life. It is not only a prerequisite for personal relationships, but also for employment prospects. If a child's language development is impaired

2009-08-17 08:00:00

PHILADELPHIA, Aug.

2009-07-28 01:00:00

PHILADELPHIA, July 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Complete Response letter today for INTUNIV(TM) (guanfacine) Extended Release from the Food and Drug Administration (FDA). This decision comes following labeling discussions with the FDA that did not result in agreement in time to meet the PDUFA date. The FDA did not identify safety concerns regarding INTUNIV in the Complete...

2009-07-22 17:15:00

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder

2009-07-22 08:00:00

PHILADELPHIA, July 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse(R)( )(lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 from the first time point measured (1.5 hours) up to the last...

2009-07-08 17:00:00

Consumers Could Save Roughly $3,000 A Year By Switching From Expensive Brand Name Drugs to Equally Effective Generics To Treat Attention Deficit Hyperactivity Disorder (ADHD) YONKERS, N.Y., July 8 /PRNewswire-USNewswire/ -- According to a new Consumer Reports Best Buy Drugs report, parents should be skeptical if their doctors offer them free prescription drug samples, especially for the treatment of attention deficit hyperactivity disorder (ADHD).

2009-07-01 11:05:35

Shire plc, the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults with Attention Deficit Hyperactivity Disorder

2009-07-01 08:00:00

VYVANSE is the first stimulant to establish duration of efficacy from two hours up to 14 hours after administration in adults with ADHD HOLLYWOOD, Fla., July 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found VYVANSE(R) (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults...

0d39cf1dae95bad33b4076507742bf311
2009-06-16 06:00:00

New evidence from a government-backed study suggests that attention deficit drugs like Ritalin and Adderall can increase the risk of sudden death.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related